USANA HEALTH SCIENCES INC
USNANYSETrading Snapshot
- Day Range
- $14.50 β $14.98
- 52-Week Range
- $12.57 β $28.52
- Volume
- $2.83B
- Avg Volume
- $3.59B
- Shares Outstanding
- 18.5M
- Next Earnings
- Nov 30, 2026
Fundamentals Snapshot
- Annual Revenue
- $925M
- Last Q Revenue
- $223M
- P/E Ratio
- -12.0
- P/S Ratio
- 0.3x
- EPS (TTM)
- $-1.20
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +1.1%
Why Investors Own USNA
- βHigh-growth profile β revenue up +33.0% YoY with expanding US Equity exposure.
- βHealthy economics β 33% gross margin and 17% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
USANA HEALTH SCIENCES INC
USNAAbout USANA HEALTH SCIENCES INC
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates

Implied Volatility Surging for USANA Health Stock Options
Investors need to pay close attention to USNA stock based on the movements in the options market lately.

Protein Pop Launches Protein Pop Balance, a Clear Prebiotic Soda with 15 Grams of Protein and 5 Grams of Fiber
Sip smart with our clear prebiotic soda β a balanced refresher for when you're on the go SALT LAKE CITY, Sept. 3, 2026 /PRNewswire/ -- Rise Wellness announced the launch of Protein Pop Balance, the newest addition to its

USANA CEO Kevin Guest Calls on People to Find a Way to Serve Others, Then Act
SALT LAKE CITY, Sept. 1, 2026 /PRNewswire/ -- USANA Health Sciences (NYSE: USNA) Chairman and CEO Kevin Guest is calling on people to make service a more intentional part of their lives with a challenge: find someone who

USANA Introduces 3-in-1 Protein, Creatine, and Electrolyte Drink Mix
New Clear Protein + Creatine Mix combines three active nutrition essentialswith 10 g of protein, 5 g of creatine, and 600+ mg of electrolytes in just 50caloriesΒ SALT LAKE CITY, Aug. 17, 2026 /PRNewswire/ -- Many active

Why Usana Health Sciences Stock Plummeted This Week
Usana's Q2 earnings came in way below expectations, and sales were also lower than expected. Usana now expects to record a loss for the full-year period.

USANA Health Sciences Q2 Earnings Call Highlights
USANA Health Sciences NYSE: USNA said its core nutritional business remained in line with expectations during the second quarter of 2026, while near-term challenges at its Hiya and Rise Wellness ventures led the company